NeilHowardSegalMDPhD

Gastrointestinal Cancer

Associate Attending Memorial Sloan Kettering Cancer Center

Overview of Dr. Segal

Dr. Neil Segal is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of the Witwatersrand and has been in practice 21 years. Dr. Segal accepts several types of health insurance, listed below. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 89 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. He has more than 90 publications and over 500 citings.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(623) 552-4736

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
NYU Grossman School of MedicineResidency, Internal Medicine, 2002 - 2005
University of the WitwatersrandClass of 1996

Certifications & Licensure

FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2025
NY State Medical License 2007 - 2025
NC State Medical License 2020 - 2022

Clinical Trials

Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer Start of enrollment: 2009 Jun 01
Completed
Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2010 Dec 01
Withdrawn
Phase 2
Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer Start of enrollment: 2014 Apr 01
Completed
Phase 1
Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer Start of enrollment: 2014 Dec 02
Completed
Phase 2
A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer Start of enrollment: 2017 Apr 24
Completed
Phase 2
Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer Start of enrollment: 2019 Mar 13
Withdrawn
Phase 2
Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer Start of enrollment: 2020 Nov 18
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

ASO Visual Abstract: Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait-Comparison of Intersphincteric Resection Versus Abdominoperineal ...
Yael Feferman, Floris S Verheij, Hannah Williams, Dana M Omer, Emmanouil P Pappou
Annals of Surgical Oncology. 2024-11-04
1 citations
Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection.
Yael Feferman, Floris S Verheij, Hannah Williams, Dana M Omer, Emmanouil P Pappou
Annals of Surgical Oncology. 2024-10-12
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer.
Neil H Segal, Jeanne Tie, Scott Kopetz, Michel Ducreux, Eric Chen
British Journal of Cancer. 2024-10-01

Lectures

First-in-human dose escalation of monalizumab plus durvalumab, with expansion in patients with metastatic microsatellite-stable colorectal cancer.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Immune Therapy: Why Don't We Have the KEY for VICTORy?
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

ASCO21 Preview - Equity: Every Patient. Every Day. EverywhereMay 27th, 2021
INNATE PHARMA : Data from Phase I of Monalizumab and Durvalumab in MSS-CRC at ASCO 2018September 12th, 2018
Atezolizumab and Cobimetinib Regimen Shows Activity in CRCJune 15th, 2016
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment